The impact of COVID-19 and COVID vaccination on cardiovascular outcomes

Akhtar, Zubair; Trent, Mallory; Moa, Aye; Tan, Timothy C.; Fröbert, Ole; MacIntyre, C. Raina

doi:10.1093/eurheartjsupp/suac123

Cited by 21 publications

(10 citation statements)

References 84 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…17 Symptoms that are both cardiac and GIT-related account for less than 20% of symptoms, with rare events being severe. 25,28 The health status of severe cases needs to be investigated to identify the cause of severe reactions.…”

Section: Discussionmentioning

confidence: 99%

The Most Common Side Effects of AstraZeneca COVID-19 Vaccine among Saudi Arabian Population: A Systematic Review

Aldali,

Abutheeb,

Al-Fahd

et al. 2023

J. Pure Appl. Microbiol.

View full text Add to dashboard Cite

In order to fight the coronavirus disease 2019 (COVID-19) pandemic, the AstraZeneca vaccine was introduced in the Saudi Arabian vaccination campaign. AstraZeneca was rapidly developed, and side effects have been reported following vaccination. This review aims to evaluate the adverse side-effects of the AstraZeneca vaccine within the Saudi population. A literature search of the national and international databases PubMed, Scopus, Google Scholar, Embase databases, and Cochrane Library using the search terms “Covid-19 vaccine”, “AstraZeneca post-vaccination,” and “Covid-19 vaccine Saudi Arabia” in combination with the terms “side effects,” “adverse effects,” and “Covid-19 AstraZeneca” was performed. Articles published before 12 January 2022 were eligible for screening. A total of seven articles met the inclusion criteria, totaling 4838 participants. The most common side effects were fever and either pain or redness at the site of the injection. Furthermore, systemic reactions to AstraZeneca accounted for approximately 80% of adverse effects following vaccination. In sum, AstraZeneca appears to have mild to moderate side effects.

show abstract

Section: Discussionmentioning

confidence: 99%

The Most Common Side Effects of AstraZeneca COVID-19 Vaccine among Saudi Arabian Population: A Systematic Review

Aldali,

Abutheeb,

Al-Fahd

et al. 2023

J. Pure Appl. Microbiol.

View full text Add to dashboard Cite

show abstract

“…Post-vaccination, acute MI rates were significantly lower than those associated with COVID-19 infection in other countries [ 72 ]. Some studies exhibit conflicting outcomes, with some suggesting that COVID-19 vaccination might decrease the risk of cardiovascular events like myocarditis and MI, while others indicate an increased risk [ 73 ]. Further investigation into the relationship between COVID-19 vaccinations and MI, considering various demographic and health-related factors, is essential to comprehensively understand the potential risks and benefits associated with vaccination.…”

Section: Reviewmentioning

confidence: 99%

Multifaceted Impact of the Coronavirus Disease 2019 (COVID-19) Pandemic on ST-Elevation Myocardial Infarction (STEMI): A Literature Review of Incidence, Treatment Modalities, and Outcomes

Choi,

Maity,

Qureshi

et al. 2024

Cureus

View full text Add to dashboard Cite

The global repercussions of coronavirus disease 2019 (COVID-19) include substantial worldwide mortality and have brought to light existing gaps in healthcare systems. Particularly, diseases requiring time-sensitive treatment, such as ST-elevation myocardial infarction (STEMI), have faced significant challenges due to the impact and revelations of the COVID-19 pandemic on healthcare infrastructure. This review addresses the impact of the pandemic on STEMI, exploring incidence, treatment modalities, and clinical outcomes. Through a critical examination of existing literature, the intricate relationship between the pandemic and cardiovascular health, specifically STEMI, is elucidated. The COVID-19 pandemic has had a significant impact on the management of STEMI, with changes in hospitalization rates, treatment strategies, and the presentation of the disease posing significant challenges. The contradictory results of COVID-19 and post-vaccine myocardial infarction, as well as gender differences in reported cases, highlight the need for further research to clarify these relationships.

show abstract

“…A recent review in 2023 found COVID-19 vaccine to be beneficial in reducing deleterious impact of COVID-19 in patients with HF 55 . It is important to note that drawing conclusions regarding the efficacy of the COVID-19 vaccine in patients with HF is premature at this stage, primarily due to the lack of RCTs.…”

Section: Role Of Covid-19 Vaccinesmentioning

confidence: 99%

Immunizing hearts: exploring the vaccination frontier in heart failure management

Shivamadhu,

Jalal,

Sandhu

et al. 2023

Annals of Medicine &Amp; Surgery

View full text Add to dashboard Cite

Heart failure (HF) is a widespread clinical condition that affects numerous individuals globally and is a leading cause of hospitalization, particularly in the elderly population. Despite efforts to manage heart failure using various pharmacological and non-pharmacological interventions, mortality and hospitalization rates remain alarmingly high. Preventive vaccination has emerged as a key measure endorsed by cardiology societies for reducing the morbidity and mortality associated with HF. This study undertakes an extensive review of existing literature to explore the role of vaccination in managing HF, focusing specifically on the immunological pathways involved and potential benefits offered by immunization in this context. This article highlights the role of various vaccines, including influenza, pneumococcal, and COVID-19 vaccines, in reducing HF-related hospitalization, mortality, and overall disease burden. Additionally, this article will delve into specific vaccines that have shown promise in heart failure management, such as influenza, pneumococcal, and COVID-19 vaccines, along with the rationale for their use, clinical trials, meta-analyses, and real-world data supporting their effectiveness in patients with heart failure. This article also considers potential challenges and obstacles to widespread vaccination in individuals with heart failure, which include vaccine hesitancy, accessibility, and adverse events related to vaccines.

show abstract

The impact of COVID-19 and COVID vaccination on cardiovascular outcomes

Cited by 21 publications

References 84 publications

The Most Common Side Effects of AstraZeneca COVID-19 Vaccine among Saudi Arabian Population: A Systematic Review

The Most Common Side Effects of AstraZeneca COVID-19 Vaccine among Saudi Arabian Population: A Systematic Review

Multifaceted Impact of the Coronavirus Disease 2019 (COVID-19) Pandemic on ST-Elevation Myocardial Infarction (STEMI): A Literature Review of Incidence, Treatment Modalities, and Outcomes

Immunizing hearts: exploring the vaccination frontier in heart failure management

Contact Info

Product

Resources

About